MedTrace Logo

Nexplanon Application Post-Abortion (NAPA)

NCT02037919 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 148

Last updated 2024-02-12

Study results available
· View outcomes & findings →

Summary

Women who receive Nexplanon immediately post abortion will be significantly more likely to be using the device 6 months after the procedure than those assigned to receive the device 2-4 weeks after the procedure.

Conditions

  • Contraception
  • Abortion, Therapeutic

Interventions

OTHER

Immediate Nexplanon Insertion

Patient will have a Nexplanon inserted within 15 minutes of her abortion

OTHER

Post-op Nexplanon Insertion

Place Nexplanon at post operative visit rather than at surgery

Sponsors & Collaborators

  • Merck Sharp & Dohme LLC

    collaborator INDUSTRY

  • The Cleveland Clinic

    collaborator OTHER

  • Family Planning Associates Medical Group, LTD

    lead OTHER

Principal Investigators

  • Miriam Cremer, MD, MPH · University of Pittsburgh

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2017-05-31
Completion
2017-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02037919 on ClinicalTrials.gov